RAG halts Evonik IPO on unfavourable capital market conditions

18 June 2012 14:23  [Source: ICIS news]

LONDON (ICIS)--The majority owner of German specialty chemicals major Evonik has decided to cancel its plan to list the company in an initial public offering (IPO), it said on Monday.

RAG-Stiftung, which holds 74.99% of Evonik, said that under current uncertain capital market conditions – in particular with regard to further developments in the eurozone - it cannot achieve IPO proceeds that reflect the company's value.

RAG did not disclose financial details.

According to reports in Germany’s financial press, RAG is valuing Evonik at around €15bn ($19bn) or more.

RAG is a German coal foundation. Proceeds from Evonik’s IPO would go towards paying for environmental and other costs related to the closure of German coal mines.

RAG’s move marks the second time it has halted Evonik’s IPO. In 2008, RAG ended IPO preparations because of unfavourable capital market conditions at the time. Instead, RAG sold a 25.01% stake of Evonik to private equity firm CVC.

($1 = €0.79)


By: Stefan Baumgarten
+1 713 525 2653



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly